These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35742165)

  • 21. 3D printing of high drug loaded dosage forms using thermoplastic polyurethanes.
    Verstraete G; Samaro A; Grymonpré W; Vanhoorne V; Van Snick B; Boone MN; Hellemans T; Van Hoorebeke L; Remon JP; Vervaet C
    Int J Pharm; 2018 Jan; 536(1):318-325. PubMed ID: 29217471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3D printed oral theophylline doses with innovative 'radiator-like' design: Impact of polyethylene oxide (PEO) molecular weight.
    Isreb A; Baj K; Wojsz M; Isreb M; Peak M; Alhnan MA
    Int J Pharm; 2019 Jun; 564():98-105. PubMed ID: 30974194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of Fused Deposition Modelling (FDM) Method of 3D Printing in Drug Delivery.
    Long J; Gholizadeh H; Lu J; Bunt C; Seyfoddin A
    Curr Pharm Des; 2017; 23(3):433-439. PubMed ID: 27784251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization of FDM 3D printing process parameters to produce haemodialysis curcumin-loaded vascular grafts.
    Basile S; Mathew E; Genta I; Conti B; Dorati R; Lamprou DA
    Drug Deliv Transl Res; 2023 Aug; 13(8):2058-2071. PubMed ID: 34642844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodegradable Poly(Lactic Acid) Nanocomposites for Fused Deposition Modeling 3D Printing.
    Bardot M; Schulz MD
    Nanomaterials (Basel); 2020 Dec; 10(12):. PubMed ID: 33371307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
    Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
    Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
    Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
    Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3D printing using powder melt extrusion.
    Boyle BM; Xiong PT; Mensch TE; Werder TJ; Miyake GM
    Addit Manuf; 2019 Oct; 29():. PubMed ID: 33907668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a Simple Mechanical Screening Method for Predicting the Feedability of a Pharmaceutical FDM 3D Printing Filament.
    Nasereddin JM; Wellner N; Alhijjaj M; Belton P; Qi S
    Pharm Res; 2018 May; 35(8):151. PubMed ID: 29855818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing.
    Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF
    J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fused Deposition Modeling (FDM) 3D Printing of the Thermo-Sensitive Peptidomimetic Drug Enalapril Maleate.
    Hoffmann L; Breitkreutz J; Quodbach J
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36365230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extrusion-based 3D printing of oral solid dosage forms: Material requirements and equipment dependencies.
    Henry S; Samaro A; Marchesini FH; Shaqour B; Macedo J; Vanhoorne V; Vervaet C
    Int J Pharm; 2021 Apr; 598():120361. PubMed ID: 33571622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3D printing hybrid materials using fused deposition modelling for solid oral dosage forms.
    Krueger L; Miles JA; Popat A
    J Control Release; 2022 Nov; 351():444-455. PubMed ID: 36184971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a quantitative method to evaluate the printability of filaments for fused deposition modeling 3D printing.
    Xu P; Li J; Meda A; Osei-Yeboah F; Peterson ML; Repka M; Zhan X
    Int J Pharm; 2020 Oct; 588():119760. PubMed ID: 32800939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. M3DISEEN: A novel machine learning approach for predicting the 3D printability of medicines.
    Elbadawi M; Muñiz Castro B; Gavins FKH; Ong JJ; Gaisford S; Pérez G; Basit AW; Cabalar P; Goyanes A
    Int J Pharm; 2020 Nov; 590():119837. PubMed ID: 32961295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3D printed medicines: A new branch of digital healthcare.
    Awad A; Trenfield SJ; Gaisford S; Basit AW
    Int J Pharm; 2018 Sep; 548(1):586-596. PubMed ID: 30033380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Near-infrared chemical imaging (NIR-CI) of 3D printed pharmaceuticals.
    Khorasani M; Edinger M; Raijada D; Bøtker J; Aho J; Rantanen J
    Int J Pharm; 2016 Dec; 515(1-2):324-330. PubMed ID: 27720877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Research on the Application of MWCNTs/PLA Composite Material in the Manufacturing of Conductive Composite Products in 3D Printing.
    Luo J; Wang H; Zuo D; Ji A; Liu Y
    Micromachines (Basel); 2018 Nov; 9(12):. PubMed ID: 30513580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations-printability-process modulation, with consecutive effects on in vitro release, stability and degradation.
    Ilyés K; Kovács NK; Balogh A; Borbás E; Farkas B; Casian T; Marosi G; Tomuță I; Nagy ZK
    Eur J Pharm Sci; 2019 Mar; 129():110-123. PubMed ID: 30610954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients.
    Gioumouxouzis CI; Tzimtzimis E; Katsamenis OL; Dourou A; Markopoulou C; Bouropoulos N; Tzetzis D; Fatouros DG
    Eur J Pharm Sci; 2020 Feb; 143():105176. PubMed ID: 31809907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.